Copley II: Long-term Outcome Follow-up Study of Osteoporotic Women Who Underwent a Local Osteo-Enhancement Procedure (LOEP) in the Proximal Femur
- Conditions
- Osteopenic WomenProximal Femur Fracture
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- AgNovos Healthcare, LLC
- Target Recruit Count
- 12
- Registration Number
- NCT06799143
GRACE - Study of AGN1 LOEP in Osteopenic and Osteoporotic Patients
- Conditions
- Osteoporosis
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- AgNovos Healthcare, LLC
- Target Recruit Count
- 44
- Registration Number
- NCT05966974
- Locations
- 🇧🇪
Vitaz, Sint-Niklaas, Belgium
RECONFIRM - Study of AGN1 LOEP in Patients with Osteoporosis
- Conditions
- Osteoporosis
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- AgNovos Healthcare, LLC
- Target Recruit Count
- 150
- Registration Number
- NCT05202678
- Locations
- 🇧🇪
AZ Nikolaas, Sint-Niklaas, Antwerpen, Belgium
STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures
- Conditions
- Vertebral Compression FractureCompression FractureVertebral Compression
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2025-05-30
- Lead Sponsor
- AgNovos Healthcare, LLC
- Target Recruit Count
- 408
- Registration Number
- NCT04835428
- Locations
- 🇺🇸
Alabama Clinical Therapeutics, Birmingham, Alabama, United States
🇺🇸Elite Pain and Spine Institute, Mesa, Arizona, United States
🇺🇸Mayo Clinic, Phoenix, Arizona, United States
RISE - Study of the AGN1 LOEP SV Kit in Patients with Vertebral Compression Fractures
- Conditions
- Vertebral CompressionVertebral Compression FractureVertebral Fracture
- First Posted Date
- 2021-03-30
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- AgNovos Healthcare, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT04821739
- Locations
- 🇩🇪
Orthopedic University Hospital Friedrichsheim, Frankfurt, Hessen, Germany
🇩🇪Sana Klinikum Offenbach GmbH, Offenbach, Germany
🇪🇸Vall d'Hebron University Hospital, Barcelona, Spain
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
- Conditions
- Fragility FractureHip FracturesOsteoporosis
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- AgNovos Healthcare, LLC
- Target Recruit Count
- 2400
- Registration Number
- NCT04796350
- Locations
- 🇦🇹
Innsbruck Hospital, Innsbruck, Austria
🇨🇦Health Sciences Centre - Eastern Health, Saint John's, Newfoundland and Labrador, Canada
🇩🇰Aarhus University Hospital, Aarhus, Denmark
CONFIRM EXTENSION - Long-term Follow-up Study of Patients Treated with AGN1 LOEP
- Conditions
- Osteoporosis
- First Posted Date
- 2020-08-13
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- AgNovos Healthcare, LLC
- Target Recruit Count
- 60
- Registration Number
- NCT04511364
- Locations
- 🇧🇪
AZ Nikolaas, Sint-Niklaas, Belgium
STRONG - Study of AGN1 LOEP for the Treatment of the Contralateral Femur After Fragility Fracture
- Conditions
- Hip FracturesOsteoporosis, Postmenopausal
- First Posted Date
- 2017-08-31
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- AgNovos Healthcare, LLC
- Target Recruit Count
- 13
- Registration Number
- NCT03268356
- Locations
- 🇭🇰
Queen Mary Hospital - Department of Orthopaedics and Traumatology, Hong Kong, Hong Kong
CONFIRM - Study of AGN1 LOEP in Patients With Osteoporosis
- Conditions
- Osteoporosis
- First Posted Date
- 2016-09-28
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- AgNovos Healthcare, LLC
- Target Recruit Count
- 60
- Registration Number
- NCT02916953
- Locations
- 🇧🇪
AZ Sint-Blasius, Dendermonde, Belgium
🇧🇪AZ Maria Middelares, Ghent, Belgium
🇧🇪AZ Groeninge - Campus Kennedylaan, Kortrijk, Belgium